NCI-CONNECT rare CNS tumor initiative: current progress and anticipated future impact
- PMID: 32642683
- PMCID: PMC7212916
- DOI: 10.1093/noajnl/vdaa022
NCI-CONNECT rare CNS tumor initiative: current progress and anticipated future impact
Keywords: clinical trials; neuro-oncology; rare tumors.
Figures
References
-
- Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
-
- Prabhu V, Cuoco C, Jung J, et al. . DDIS-20. Imipridone structure activity relationship uncovers ONC206 as the next bitopic DRD2 antagonist for oncology with differentiated receptor pharmacology. Neuro Oncol. 2019;21(suppl_6):vi67–vi67.
Publication types
LinkOut - more resources
Full Text Sources